Brennan Christopher Anthony, Morrissey Brian, Dubois-Marshall Sylvie, McAteer Dympna, Qadir Abdul, Ramsay George
BJR Open. 2020 Dec 21;2(1):20200044. doi: 10.1259/bjro.20200044. eCollection 2020.
The SARS-CoV2 infection is associated with high mortality for individuals who undergo emergency surgery. The United Kingdom surgical associations and Colleges of Surgeons collectively recommended the addition of CT Thorax to all emergency CT abdomen/pelvis imaging in order to help identify possible COVID-19 patients. Early identification of these patients would lead to optimal treatment strategies for the patient and protection for staff members. However, an extension of CT would be associated with increased irradiation doses for the patient, and its diagnostic relevance was unclear.
This was a retrospective observational review looking at all surgical admissions that required a CT Thorax/Abdomen/Pelvis across 7 weeks during the COVID-19 pandemic, across four Scottish Hospitals. CT thorax investigations (of non-surgical patients) were also re-assessed by a single radiologist to assess the extent of pathology identified at the lung bases (and therefore would be included in a standard CT abdomen and pelvis).
Of 216 patients identified who had a CT thorax/Abdomen/Pelvis during the timeframe, 5 were diagnosed with COVID-19. During this timeframe, 77 patients underwent solely CT thorax. Across the entire cohort, 98% of COVID pathology was identified at the lung bases. The estimated sensitivity and specificity of CT thorax was 60 and 86.4% respectively.
In a region with relatively low prevalence of SARS-COV2 infection, inclusion of CT Thorax in surgical admission imaging does not significantly contribute to identification and management of SARS-COV2 patients. We therefore suggest that imaging the lung bases can be sufficient to raise clinical suspicion of COVID-19.
This paper adds further evidence to that from other single UK centres that the addition of CT chest for all patients does not yield any further diagnostic information regarding coronavirus. Additionally, rapid SARS-CoV-2 testing in the UK (which is currently widely available) further demonstrates that inclusion of the entire chest during CT examination of the acute abdomen is not required.
对于接受急诊手术的患者,感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)会导致高死亡率。英国外科协会和外科医学院共同建议,在所有急诊腹部/盆腔CT成像中增加胸部CT,以帮助识别可能感染新型冠状病毒肺炎(COVID-19)的患者。尽早识别这些患者将为患者带来最佳治疗策略,并保护医护人员。然而,增加胸部CT会使患者的辐射剂量增加,其诊断相关性尚不清楚。
这是一项回顾性观察性研究,观察了在COVID-19大流行期间,苏格兰四家医院7周内所有需要进行胸部/腹部/盆腔CT检查的外科住院患者。一名放射科医生还对(非手术患者的)胸部CT检查结果进行了重新评估,以评估在肺底部发现的病变范围(因此将包含在标准的腹部和盆腔CT中)。
在该时间段内确定的216例接受胸部/腹部/盆腔CT检查的患者中,有5例被诊断为COVID-19。在此期间,77例患者仅接受了胸部CT检查。在整个队列中,98%的COVID病变在肺底部被发现。胸部CT的估计敏感性和特异性分别为60%和86.4%。
在SARS-CoV-2感染率相对较低的地区,在外科住院患者的成像检查中增加胸部CT对SARS-CoV-2患者的识别和管理没有显著帮助。因此,我们建议对肺底部进行成像足以引起对COVID-19的临床怀疑。
本文为英国其他单一中心的研究结果提供了进一步证据,即对所有患者增加胸部CT检查不会产生任何关于冠状病毒的进一步诊断信息。此外,英国目前广泛可用的快速SARS-CoV-2检测进一步表明,在急性腹部CT检查时不需要对整个胸部进行成像。